The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 1, 2011, Pages 166-170

  Meral, Cihan ^a   Cekmez, Ferhat ^a   Pirgon, Ozgur ^a   Tanju, Ilhan Asya ^a   Ipcioglu, Osman Metin ^a   Karademir, Ferhan ^a   Gocmen, Ismail ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

adiponectin; insulin resistance; neonate; Visfatin

Indexed keywords

ADIPONECTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADIPONECTIN BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LARGE FOR GESTATIONAL AGE; MALE; NEWBORN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE BLOOD LEVEL; PRIORITY JOURNAL; SMALL FOR DATE INFANT;

ADIPONECTIN; BIRTH WEIGHT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN RESISTANCE; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 78650152786     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.482604     Document Type: Article

References (25)

1. Lihn AS, Pedersen SB, Richelsen B. Adiponectin:action, regulation and association to insulin sensitivity. Obes Rev 2005;6:13-21.
2. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23:963-974. (Pubitemid 39243008)
3. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86: 1930-1935. (Pubitemid 32472900)
4. Punthakee Z, Delvin EE, O'loughlin J, Paradis G, Levy E, Platt RW, Lambert M. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab 2006;91:2119-2125. (Pubitemid 43854993)
5. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;21:426-430. (Pubitemid 40139988)
6. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006;49:1909-1914. (Pubitemid 44025046)
7. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-99.
8. Hammarstedt A, Sopasakis VR, Gogg S, et al. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006;91:1181-1184. (Pubitemid 43357799)
9. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood:association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115:290-296.
10. Langer O. Fetal macrosomia:etiologic factors. Clin Obstet Gynecol 2000;43:283-297.
11. Catalano P, Kirwan J, Haugel-de Mouzon S, et al. Gestational diabetes and insulin resistance: role in short- and longterm implications for mother and fetus. J Nutr 2003;133: 1674-1683.
12. Plagemann A, Hander T, Kohlhoff R, et al. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia 1997;40: 1094-1100. (Pubitemid 27381973)
13. Hales CN, Barker DJ. Type 2 (noninsulin-dependent) diabetes mellitus:the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
14. Miller HC, Hassanein K. Diagnosis of impaired fetal growth in newborn infants. Pediatrics 1971;48:511-522.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985;28: 412-419. (Pubitemid 15018832)
16. Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S. Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004;104:720-726. (Pubitemid 40458799)
17. Evagelidou E, Kiortsis D, Bairaktari E, et al. Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care 2006;29:1197-1201. (Pubitemid 44125909)
18. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. The Fungata Study. Diabetes Care 2003;26:2015-2020. (Pubitemid 41184244)
19. Malamitsi-Puchner A, Despina DB, Boutsikou M, et al. Pediatrics 2007;6:1314-1318.
20. Cianfarani S, Martinez C, Maiorana A, et al. Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catchup growth. J Clin Endocrinol Metab 2004;89:1346-1351. (Pubitemid 38368435)
21. Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho SC, Chu CH. Cord plasma concentrations of adiponectin and leptin in healthy term neonates:positive correlation with birthweight and neonatal adiposity. Clin Endocrinol 2004; 61:88-93.
22. Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 2004;56:690-693. (Pubitemid 39403391)
23. Tamakoshi K, Yatsuya H, Wada K, et al. Low birth weight is associated with reduced adiponectin concentration in adult. Ann Epidemiol 2006;16:669-674. (Pubitemid 44209376)
24. Kim CS, Park JS, Park J, et al. Does birthweight predict adolescent adiponectin levels? Clin Endocrinol 2006;64:162-168.
25. Harrington TA, Thomas EL, Frost G, Modi N, Bell JD. Distribution of adipose tissue in the newborn. Pediatr Res 2004;55:437-441. (Pubitemid 38240822)